Home » Stocks » Applied Molecular Transport

Applied Molecular Transport, Inc. (AMTI)

Stock Price: $33.58 USD 0.57 (1.73%)
Updated Sep 18, 2020 4:00 PM EDT - Market closed
After-hours: $33.58 0.00 (-0.01%) Sep 18, 4:29 PM

Stock Price Chart

Key Info

Market Cap 1.17B
Revenue (ttm) n/a
Net Income (ttm) n/a
Shares Out 34.85M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Sep 18, 2020
Last Price $33.58
Previous Close $33.01
Change ($) 0.57
Change (%) 1.73%
Day's Open 33.00
Day's Range 31.95 - 35.34
Day's Volume 2,245,478
52-Week Range 17.05 - 35.34

More Stats

Market Cap 1.17B
Enterprise Value 1.01B
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 34.85M
Float 20.23M
EPS (basic) n/a
EPS (diluted) n/a
FCF / Share n/a
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 291,743
Short Ratio 1.03
Short % of Float 1.41%
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 6.97
Revenue n/a
Operating Income n/a
Net Income n/a
Free Cash Flow n/a
Net Cash 163.37M
Net Cash / Share 4.69
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA n/a
ROE n/a
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (3)

Buy 3
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

(3.25% upside)
Current: $33.58
Target: 34.67
*Average 12-month price target from 3 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Operating Income-28.29-29.87
Net Income-28.04-29.87
Shares Outstanding7.367.32
Earnings Per Share-3.81-4.08
Operating Cash Flow-26.97-27.45
Capital Expenditures-2.15-0.55
Free Cash Flow-29.12-28.00
Cash & Equivalents32.5120.29
Net Cash / Debt32.5120.29
Book Value-71.70-44.14
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Applied Molecular Transport, Inc.
Country United States
Employees 50
CEO Tahir Mahmood

Stock Information

Ticker Symbol AMTI
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: AMTI
IPO Date June 5, 2020


Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the development of a pipeline of oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. Its lead product candidate is AMT-101, an oral gastrointestinal (GI) selective interleukin 10 that has completed a Phase 1b clinical trial in patients with ulcerative colitis (UC). The company, through its technology platform designs and develops various oral biologic therapeutic modalities, such as peptides, proteins, antibodies, antibody fragments, and RNA therapeutics. In addition, it engages in the development of AMT-126, a GI-selective oral fusion of rhIL-22 for diseases related to intestinal epithelium barrier function defects. Applied Molecular Transport Inc. was founded in 2010 and is headquartered in South San Francisco, California. Address: 1 Tower Place, South San Francisco, CA, United States, 94080